Education
About Us
Working with TipRanks
Follow Us
Allovir Inc (ALVR)
NASDAQ:ALVR
Total Valuation
AlloVir has a market cap or net worth of $30.20M. The enterprise value is ―.
Market Cap$30.20M
Enterprise Value―
Share Statistics
AlloVir has 5,043,357 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,043,357
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AlloVir’s return on equity (ROE) is -0.52 and return on invested capital (ROIC) is -57.76%.
Return on Equity (ROE)-0.52
Return on Assets (ROA)-0.50
Return on Invested Capital (ROIC)-57.76%
Return on Capital Employed (ROCE)-0.58
Revenue Per Employee0.00
Profits Per Employee-524.72K
Employee Count112
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of AlloVir is -18.97. AlloVir’s PEG ratio is -0.32.
PE Ratio-18.97
PS Ratio―
PB Ratio9.81
Price to Fair Value9.84
Price to FCF-0.72
Price to Operating Cash Flow-16.42
PEG Ratio-0.32
Income Statement
In the last 12 months, AlloVir had revenue of 0.00 and earned -58.77M in profits. Earnings per share was -0.51.
Revenue0.00
Gross Profit0.00
Operating Income-65.44M
Pretax Income-58.77M
Net Income-58.77M
EBITDA-65.44M
Earnings Per Share (EPS)-0.51
Cash Flow
In the last 12 months, operating cash flow was -67.70M and capital expenditures 0.00, giving a free cash flow of -67.70M billion.
Operating Cash Flow-67.70M
Free Cash Flow-67.70M
Free Cash Flow per Share-13.42
Dividends & Yields
AlloVir pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.85
52-Week Price Change-49.31%
50-Day Moving Average9.79
200-Day Moving Average14.55
Relative Strength Index (RSI)43.86
Average Volume (3m)11.13K
Important Dates
AlloVir upcoming earnings date is Oct 31, 2024, TBA Not Confirmed.
Last Earnings DateAug 1, 2024
Next Earnings DateOct 31, 2024
Ex-Dividend Date―
Financial Position
AlloVir as a current ratio of 22.63, with Debt / Equity ratio of 0.00%
Current Ratio22.63
Quick Ratio22.63
Debt to Market Cap0.00
Net Debt to EBITDA1.81
Interest Coverage Ratio0.00
Taxes
In the past 12 months, AlloVir has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
AlloVir EV to EBITDA ratio is -737.51, with an EV/FCF ratio of -712.85.
EV to Sales0.00
EV to EBITDA-737.51
EV to Free Cash Flow-712.85
EV to Operating Cash Flow-712.85
Balance Sheet
AlloVir has $118.29M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$118.29M billion.
Cash & Marketable Securities$118.29M
Total Debt$0.00
Net Cash-$118.29M
Net Cash Per Share-$23.45
Tangible Book Value Per Share$0.98
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for AlloVir is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast72.12%